Cellular Plasticity in Malignant Transformation: Mesothelial Cells
Open Access
- 29 April 2026
- journal article
- review article
- Published by S. Karger AG in Pathobiology
- p. 1-16
Abstract
Background: Mesothelial proliferations range from reactive lesions to benign and malignant tumors, bearing witness to the plasticity of these cells. Their diagnosis often requires combination of morphological assessment, immunohistochemistry, and molecular testing. Summary: Considerable progress has been made in recent years in all the above aspects. The separation of reactive from neoplastic mesothelial proliferations has become more robust. Mesothelioma in situ is now recognized as precursor of invasive mesothelioma and better tools exist for its differentiation from benign mimics. Differentiating mesothelial tumors from other malignancies, including metastatic carcinomas, sarcomas, and other tumors, is now more easily achieved. Genetic conditions which predispose to development of mesothelioma at a young age have been identified and characterized. These issues are discussed in this review. Key messages: Mesothelial pathology is an evolving field and more knowledge of these processes is likely to be gained in coming years. The diagnosis of these tumors requires experts with subspecialty in cytology, thoracic, soft tissue/bone, and gynecologic pathology, cooperating with surgeons, radiologists, and oncologists at specialized centers.Keywords
This publication has 71 references indexed in Scilit:
- The specificity of HEG1 as mesothelioma marker depends on the differential diagnosisVirchows Archiv, 2026
- Cytopathologic Features of Metastatic Malignant Mesothelioma With SMARCB1 ( INI ‐1) Deficient Diagnosed by Ultrasound‐Guided Fine‐Needle Aspiration: A Case ReportDiagnostic Cytopathology, 2025
- Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studiesESMO Open, 2023
- Peritoneal papillary mesothelioma in situ: BAP1 mutation with indolent behavior for 15 yearsVirchows Archiv, 2023
- The cytological features of effusions with mesothelioma in situ: A report of 9 casesDiagnostic Cytopathology, 2023
- NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphologyGenes, Chromosomes and Cancer, 2022
- Analysis of early pleural fluid samples in patients with mesothelioma: A case series exploration of morphology, BAP1, and CDKN2A status with implications for the concept of mesothelioma in situ in cytologyCancer Cytopathology, 2022
- The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference CenterHuman Pathology, 2017
- Adenomatoid tumors of the female and male genital tract. A comparative clinicopathologic and immunohistochemical analysis of 47 cases emphasizing their site-specific morphologic diversityVirchows Archiv, 2011
- Primary synovial sarcoma of the pleura: beware of misdiagnosisEuropean Journal of Internal Medicine, 2004